Wed, June 6, 2018
Tue, June 5, 2018
Mon, June 4, 2018
Fri, June 1, 2018
Thu, May 31, 2018
Wed, May 30, 2018
Tue, May 29, 2018
Fri, May 25, 2018
Thu, May 24, 2018
Wed, May 23, 2018
Tue, May 22, 2018
Mon, May 21, 2018
Fri, May 18, 2018
Thu, May 17, 2018
Wed, May 16, 2018
Tue, May 15, 2018
Mon, May 14, 2018
Fri, May 11, 2018
Thu, May 10, 2018
Wed, May 9, 2018
Tue, May 8, 2018
Mon, May 7, 2018

Alex Arfaei Maintained (ABBV) at Sell with Decreased Target to $78 on, May 23rd, 2018


//stocks-investing.news-articles.net/content/201 .. ith-decreased-target-to-78-on-may-23rd-2018.html
Published in Stocks and Investing on by   Print publication without navigation


Alex Arfaei of BMO Capital, Maintained "AbbVie Inc." (ABBV) at Sell with Decreased Target from $81 to $78 on, May 23rd, 2018.

Alex has made no other calls on ABBV in the last 4 months.



There are 4 other peers that have a rating on ABBV. Out of the 4 peers that are also analyzing ABBV, 3 agree with Alex's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Vamil Divan of "Credit Suisse" Maintained at Hold with Decreased Target to $104 on, Friday, April 27th, 2018
  • Geoff Meacham of "Barclays" Maintained at Hold with Decreased Target to $102 on, Thursday, April 5th, 2018
  • Geoffrey Porges of "Leerink Swann" Downgraded from Buy to Hold on, Monday, January 29th, 2018


This is the rating of the analyst that currently disagrees with Alex


  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $145 on, Friday, February 2nd, 2018